Aldesleukin Completed Phase 2 Trials for Stage IV Renal Cell Cancer / Renal Cell Carcinoma Recurrent Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00126490Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer